TrialScope has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials.emdgroup.com. This site is designed to educate and inform patients, caregivers, the public, patient advocacy groups and healthcare professionals (HCPs) about the clinical trial journey, as well as provide specific information…
Mass flow controllers in bioprocessing: Here are the basics
Exercising greater process control and delivering improved yields are constant challenges for bioprocessing operations. Here’s how mass flow controllers help. Joe Sipka, Brooks Instrument The mass flow controller (MFC) is commonly used in many bioprocessing systems to manage the flow of different gases into bioreactor chambers. Intelligent MFC technology with digital-based flow-control capabilities can help…
ACG Group introduces next-gen pharma production, inspection and packaging equipment
ACG Group (Mumbai) this week rolled out what it described as a comprehensive portfolio of pharmaceutical production, inspection and packaging equipment. The portfolio draws on equipment technology from two of the company’s four business units: ACG Engineering and ACG Inspection. The machines — ranging from tablet presses to blister and carton packing equipment to serialization…
Hurry Up and Wait: Brexit from a Regulatory Point of View
You Brexit, You Buy It – Europe and the New Regulatory – Part 1 of 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates With Brexit looming, questions and concerns hover like a grey cloud over the UK pharmaceutical industry. Industry insiders and colleagues in London found that the confusion surrounding what…
Hurry Up and Wait: Brexit from a Regulatory Point of View – Part 2
You Brexit, You Buy It – Europe and the New Regulatory – Part 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates In Brexit Part 1, I expressed my Brexit thoughts as Theresa May was providing a tearful resignation and now the United Kingdom has the return of an energetic Boris Johnson,…
Pfizer to Buy Array Biopharma in Deal Worth $11.4B
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used…
Psoriasis Treatment Market to Gain $121 Billion by 2024
As reported by TMR, the global psoriasis treatment market is prognosticated to exhibit a 5.10 percent CAGR over the forecast period from 2016 to 2024. The market was estimated to be worth $7.8 bn in 2015 and is forecasted to reach $12.1 bn by 2024. North America is predicted to emerge as the leading region…
ADHD Drugs Market Will Register a CAGR of Almost 6 Percent by 2023
The rising incidence rate of ADHD among children is one of the critical factors that will trigger the growth of the attention deficit hyperactivity disorder drugs market. The expansion of the patient pool with positive ADHD symptoms is fueling the demand for ADHD therapies. As per the CDC, in 2016. Approximately 9.4 percent of children…
